NCT01672879 · Interventional trial
Simtuzumab (SIM, GS-6624) in the Treatment of Cirrhosis Due to NASH
Overall registry status Terminated
Phase 2
Conditions Liver Fibrosis Due to NASH
Delaware Valley sites
- University of Pennsylvania Hospital · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory